Myelo Therapeutics
Pre-clinicalWe develop medical countermeasures and cancer-supportive care therapies to protect the public from lethal radiation attacks and patients from unintended chemo-radiation effects. Myelo Therapeutics GmbH is a subsidiary of Pentixapharm AG.
Founded
2015
Focus
Small Molecules
About
We develop medical countermeasures and cancer-supportive care therapies to protect the public from lethal radiation attacks and patients from unintended chemo-radiation effects. Myelo Therapeutics GmbH is a subsidiary of Pentixapharm AG.
Company Info
TypePrivate
Founded2015
LocationBerlin, Germany
StagePre-clinical
Contact
SIMILAR COMPANIES
300Microns
Pre-clinical · Munich
BetaSense
Pre-clinical · Berlin
AB Diagnostic Systems
Pre-clinical · Jena
bbi-biotech
Pre-clinical · Berlin
Mireca Medicines
Pre-clinical · Munich
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile